Citius Oncology Inc (CTOR)

1.10 -0.90%

Citius Oncology Inc (CTOR) is currently trading at $1.10. This represents a loss of 0.9% from the previous session. With a market capitalization of $0.10B, CTOR is a key component of the Biotechnology sector. Investors looking to trade CTOR should compare margin rates and options platforms to optimize their portfolio management.

Broker Promotion
Get 15 Free Stocks on Moomoo → T&Cs Apply. Trade CTOR commission-free.
Trading Platform Comparison
Moomoo
  • Min Deposit: $0
  • Commissions: $0
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Good for small traders
IBKR
  • Min Deposit: $0
  • Commissions: $0–$0.005/share
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Professional-level tools
Ameritrade
  • Min Deposit: $0
  • Commissions: $0
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Strong research tools
Webull
  • Min Deposit: $0
  • Commissions: $0
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Easy mobile app
AI Market Sentiment

As of today, Citius Oncology Inc (CTOR) shows a bearish trend. Analysts are watching the 1.12 level closely.

Fundamentals
Mkt Cap0.10B
P/E Ratio0.0000
Volume101,914
Others Watching (By Market Cap)
IRD
Opus Genetics I $3.49
-4.12% SGMT
Sagimet Bioscie $6.13
+2.87% KLRS
Kalaris Therape $10.64
-3.01% WHWK
Whitehawk Thera $3.27
+4.49% BCIC
BCP Investment $11.57
+2.25%
60-Day Technical Chart
Advanced Charting

Need more indicators for CTOR? Use the world's #1 platform.

Open CTOR on TradingView →
Charting Platforms
TradingView

Advanced charts & indicators, web & mobile

StockCharts

Technical analysis charts with overlays & indicators

BarCharts

Market data, charts, and technical signals

Finviz

Visual stock charts & heatmaps

Yahoo Finance Charts

Basic interactive charts with indicators

Side-by-Side: Stocks Near $1
Metric CTOR
-0.90% 		ABTC
+3.43% 		AMC
+0.00% 		FUBO
+2.16%
Price $1.10 $1.06 $1.17 $1.20
Mkt Cap $0.10B $0.98B $0.62B $1.55B
- View → View → View →
Latest Headlines
Citius Oncology (CTOR) Expands LYMPHIR Distribution to Europe Through Exclusive Agreement With Uniphar Finviz • Feb 24, 2026 Citius Oncology (CTOR) Expands LYMPHIR Distribution to Europe Through Exclusive Agreement With Uniphar Insider Monkey • Feb 24, 2026 Citius Oncology Announces $18 Million Concurrent Registered Direct Offering and Private Placement Priced At-The-Market Under Nasdaq Rules PR Newswire • Dec 9, 2025 First LYMPHIR cancer drug sales bring in $3.9M for Citius Oncology Stock Titan • Feb 13, 2026 Citius Oncology, Inc. (NASDAQ:CTOR) stock most popular amongst public companies who own 79%, while individual investors hold 14% Yahoo Finance • Sep 26, 2025
● Gemini Agentic AI Analyst Insight for CTOR
Market Education
View All Articles →
External Research